{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:28:42Z","timestamp":1791188922485,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.ijantimicag.2003.08.007","type":"journal-article","created":{"date-parts":[[2004,2,10]],"date-time":"2004-02-10T10:17:53Z","timestamp":1076408273000},"page":"240-246","source":"Crossref","is-referenced-by-count":17,"title":["Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapy"],"prefix":"10.1016","volume":"23","author":[{"given":"Mark E","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A","family":"Karlowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah C","family":"Draghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clyde","family":"Thornsberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F","family":"Sahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip","family":"Nathwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2003.08.007_BIB1","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJM199704033361406","article-title":"Osteomyelitis","volume":"36","author":"Lew","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2003.08.007_BIB2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0002-9343(03)00231-6","article-title":"Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy","volume":"114","author":"Tice","year":"2003","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijantimicag.2003.08.007_BIB3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1473-3099(01)00094-9","article-title":"Systematic review and meta-analysis of antibiotic therapy for bone and joint infections","volume":"1","author":"Stengel","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2003.08.007_BIB4","first-page":"187","article-title":"Osteomyelitis","volume":"2","author":"Prabhakar","year":"2000","journal-title":"Curr Treat Option Infect Dis"},{"key":"10.1016\/j.ijantimicag.2003.08.007_BIB5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/CMR.8.4.557","article-title":"\u03b2-Lactamases in laboratory and clinical resistance","volume":"8","author":"Livermore","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2003.08.007_BIB6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0195-6701(95)90050-0","article-title":"New threats to the control of methicillin resistant Staphylococcus aureus","volume":"30","author":"Casewell","year":"1995","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2003.08.007_BIB7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1086\/520195","article-title":"Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the surveillance network database\u2014USA","volume":"29","author":"Sahm","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2003.08.007_BIB8","unstructured":"Methods for dilution antimicrobial tests for bacteria that grow aerobically. NCCLS document M7-A5. 5th ed. Wayne, PA: National Committee for Clinical Laboratory Standards; 2000."},{"key":"10.1016\/j.ijantimicag.2003.08.007_BIB9","unstructured":"Performance standards for antimicrobial susceptibility testing. NCCLS document M100-S11. Eleventh Informational Supplement. Wayne, PA: National Committee for Clinical Laboratory Standards; 2001."},{"key":"10.1016\/j.ijantimicag.2003.08.007_BIB10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0732-8893(99)00117-0","article-title":"Screening and confirmatory testing for extended spectrum \u03b2-lactamases (ESBL) in Escherichia coli","volume":"36","author":"Hadziyannis","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2003.08.007_BIB11","first-page":"2413","article-title":"Diagnosis and management of osteomyelitis","volume":"63","author":"Carek","year":"2001","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ijantimicag.2003.08.007_BIB12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1086\/341417","article-title":"Osteomyelitis in elderly patients","volume":"35","author":"Cunha","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2003.08.007_BIB13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0924-8579(02)00010-9","article-title":"Ceftriaxone activity against Gram-positive and Gram-negative pathogens isolated in US clinical microbiology laboratories from 1996 to 2000: results from The Surveillance Network\u00ae (TSN\u00ae) Database\u2014USA","volume":"19","author":"Karlowsky","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2003.08.007_BIB14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/jac\/47.4.483","article-title":"The penetration of ceftriaxone and cefamandole into bone, fat and haematoma and relevance of serum protein binding to their penetration into bone","volume":"47","author":"Lovering","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2003.08.007_BIB15","doi-asserted-by":"crossref","unstructured":"Scaglione F, De Martini G, Peretto L, Ghezzi R, Baratelli M, Arcidiacono et al. Pharmacokinetic study of cefodizime and ceftriaxone in sera and bones of patients undergoing hip arthroplasty. Antimicrob Agents Chemother 1997;41: 2292\u201394","DOI":"10.1128\/AAC.41.10.2292"},{"key":"10.1016\/j.ijantimicag.2003.08.007_BIB16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00003495-200059003-00005","article-title":"Place of parenteral cephalosporins in the ambulatory setting: clinical evidence","volume":"59","author":"Nathwani","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2003.08.007_BIB17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000048563","article-title":"The use of outpatient parenteral antimicrobial therapy in the management of osteomyelitis: data from the outpatient parenteral antimicrobial therapy outcomes registries","volume":"47","author":"Tice","year":"2001","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2003.08.007_BIB18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/jac\/dkg061","article-title":"Cost-minimization analysis and audit of antibiotic management of bone and joint infections with ambulatory teicoplanin, in-patient care or outpatient oral linezolid therapy","volume":"51","author":"Nathwani","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2003.08.007_BIB19","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/jac\/dkf215","article-title":"The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin","volume":"50","author":"Moise","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2003.08.007_BIB20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/313620","article-title":"Ceftriaxone therapy for staphylococcal osteomyelitis: a review","volume":"30","author":"Guglielmo","year":"2000","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857903004096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857903004096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T17:21:18Z","timestamp":1585588878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857903004096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0924857903004096"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2003.08.007","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}